Kite Pharma, Inc. General and Administrative Expense
Kite Pharma, Inc. reported General and Administrative Expense of $41.10 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2017-08-08
- Kite Pharma, Inc. general and administrative expense for the quarter ending 2017-06-30 was $41.10M, a 73.33% increase year-over-year.
- Kite Pharma, Inc. general and administrative expense for the quarter ending 2017-03-31 was $35.84M, a 114.84% increase year-over-year.
- Kite Pharma, Inc. general and administrative expense for the quarter ending 2016-12-31 was $32.38M, a 119.37% increase year-over-year.
- Kite Pharma, Inc. general and administrative expense for the quarter ending 2016-09-30 was $25.03M, a 124.80% increase year-over-year.
- Kite Pharma, Inc. general and administrative expense for fiscal 2016 was $97.42M, a 117.27% increase from fiscal 2015.
- Kite Pharma, Inc. general and administrative expense for fiscal 2015 was $44.84M, a 230.45% increase from fiscal 2014.
- Kite Pharma, Inc. general and administrative expense for fiscal 2014 was $13.57M, a 913.37% increase from fiscal 2013.
- Kite Pharma, Inc. general and administrative expense for fiscal 2013 was $1.34M, a 73.90% increase from fiscal 2012.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 6 month as first filed | General and Administrative Expense 9 month | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | $41.10M 10-Q · filed 2017-08-08 | $76.47M 10-Q · filed 2017-08-08 | $109.32M derived: sum of 3 quarters · filed 2017-08-08 | $134.35M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2017-03-31 | $35.84M 10-Q · filed 2017-05-08 | $68.22M derived: sum of 2 quarters · filed 2017-05-08 | $93.25M derived: sum of 3 quarters · filed 2017-05-08 | $116.96M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-12-31 | $32.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $57.41M derived: sum of 2 quarters · filed 2017-02-28 | $81.12M derived: sum of 3 quarters · filed 2017-08-08 | $97.42M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $25.03M 10-Q · filed 2016-11-09 | $48.74M derived: sum of 2 quarters · filed 2017-08-08 | $65.05M 10-Q · filed 2016-11-09 | $80.19M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-06-30 | $23.71M 10-Q · filed 2017-08-08 | $23.52M 10-Q · filed 2016-08-08 | $40.40M 10-Q · filed 2017-08-08 | $40.01M 10-Q · filed 2016-08-08 | $55.16M derived: sum of 3 quarters · filed 2017-08-08 | $66.29M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $16.68M 10-Q · filed 2017-05-08 | $16.49M 10-Q · filed 2016-05-09 | $31.44M derived: sum of 2 quarters · filed 2017-05-08 | $42.58M derived: sum of 3 quarters · filed 2017-05-08 | $52.35M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | $14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $25.89M derived: sum of 2 quarters · filed 2017-02-28 | $35.67M derived: sum of 3 quarters · filed 2017-02-28 | $44.84M 10-K · filed 2017-02-28 | $44.21M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $11.13M 10-Q · filed 2016-11-09 | $20.91M derived: sum of 2 quarters · filed 2016-11-09 | $30.08M 10-Q · filed 2016-11-09 | $35.48M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $9.77M 10-Q · filed 2016-08-08 | $18.95M 10-Q · filed 2016-08-08 | $24.34M derived: sum of 3 quarters · filed 2017-02-28 | $27.73M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $9.17M 10-Q · filed 2016-05-09 | $14.57M derived: sum of 2 quarters · filed 2017-02-28 | $17.95M derived: sum of 3 quarters · filed 2017-02-28 | $21.67M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.78M derived: sum of 2 quarters · filed 2017-02-28 | $12.50M derived: sum of 3 quarters · filed 2017-02-28 | $13.57M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $3.38M 10-Q · filed 2015-11-12 | $7.10M derived: sum of 2 quarters · filed 2015-11-12 | $8.17M 10-Q · filed 2015-11-12 | $8.67M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $3.72M 10-Q · filed 2015-08-10 | $4.79M 10-Q · filed 2015-08-10 | $5.29M derived: sum of 3 quarters · filed 2016-02-29 | $5.63M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $1.07M 10-Q · filed 2015-05-15 | $1.57M derived: sum of 2 quarters · filed 2016-02-29 | $1.91M derived: sum of 3 quarters · filed 2016-02-29 | $2.20M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $839.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.13M derived: sum of 3 quarters · filed 2016-02-29 | $1.34M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $339.00K 10-Q · filed 2014-11-14 | $626.00K derived: sum of 2 quarters · filed 2014-11-14 | $839.00K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $287.00K 10-Q · filed 2014-08-14 | $500.00K 10-Q · filed 2014-08-14 | |||||
| 2012-12-31 | $770.00K 10-K · filed 2015-03-26 |